Radioligand and fluorescent binding assays, competition binding, recombinant receptor-expressing cell lines, functional readouts through a defined coupling pathway, and antagonist controls demonstrating that an effect is receptor-mediated
I generally recommend starting with the lower dose of 0.25 mg for the first week before considering increases
Lan H, Su Y, Liu Y, Deng C, Wang J, Chen T, et al
Acknowledgements We thank members of the Thompson laboratory at MSKCC, H
Safety Considerations and Who Should Discuss GHK-Cu with a Provider GHK-Cu is not FDA-approved for any indication, and safety data in humans is minimal
S.AlaviM